Clinical Trials · NCT01295060

Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly

Name: Long-term Safety and Efficacy Study of Octreotide Implant in Patients With Acromegaly
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

TerminatedPhase 3Octreotide

Phase: Phase 3
Recruitment status: Terminated
Sponsor: Endo USA Inc., a Keenova Therapeutics Company
Enrollment: 12
Start date: Feb 2011
Locations: 6 sites, United States
Primary endpoint: Long term safety and tolerability of the Octreotide Implant

View Octreotide compound reference